Sutro Biopharma (STRO) Revenue & Revenue Breakdown
Sutro Biopharma Revenue Highlights
Latest Revenue (Y)
$102.48M
Latest Revenue (Q)
$9.69M
Main Segment (Y)
Research and Development Services
Main Geography (Y)
Collaboration Revenue
Sutro Biopharma Revenue by Period
Sutro Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $102.48M | 65.18% |
| 2024-12-31 | $62.04M | -59.64% |
| 2023-12-31 | $153.73M | 126.84% |
| 2022-12-31 | $67.77M | 9.52% |
| 2021-12-31 | $61.88M | 44.84% |
| 2020-12-31 | $42.72M | -0.03% |
| 2019-12-31 | $42.74M | 11.24% |
| 2018-12-31 | $38.42M | -25.75% |
| 2017-12-31 | $51.74M | -13.38% |
| 2016-12-31 | $59.73M | - |
Sutro Biopharma generated $102.48M in revenue during NA 2025, up 65.18% compared to the previous quarter, and up 239.89% compared to the same period a year ago.
Sutro Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $9.69M | -84.79% |
| 2025-06-30 | $63.74M | 266.37% |
| 2025-03-31 | $17.40M | 17.49% |
| 2024-12-31 | $14.81M | 73.81% |
| 2024-09-30 | $8.52M | -66.86% |
| 2024-06-30 | $25.71M | 97.62% |
| 2024-03-31 | $13.01M | -88.56% |
| 2023-12-31 | $113.72M | 571.95% |
| 2023-09-30 | $16.92M | 62.54% |
| 2023-06-30 | $10.41M | -17.85% |
| 2023-03-31 | $12.67M | 46.83% |
| 2022-12-31 | $8.63M | -65.67% |
| 2022-09-30 | $25.15M | -10.50% |
| 2022-06-30 | $28.10M | 376.45% |
| 2022-03-31 | $5.90M | -44.65% |
| 2021-12-31 | $10.65M | 25.09% |
| 2021-09-30 | $8.52M | -69.64% |
| 2021-06-30 | $28.05M | 91.33% |
| 2021-03-31 | $14.66M | 77.10% |
| 2020-12-31 | $8.28M | -53.55% |
| 2020-09-30 | $17.82M | 88.22% |
| 2020-06-30 | $9.47M | 32.40% |
| 2020-03-31 | $7.15M | -36.74% |
| 2019-12-31 | $11.30M | -7.92% |
| 2019-09-30 | $12.28M | 16.65% |
| 2019-06-30 | $10.53M | 21.97% |
| 2019-03-31 | $8.63M | -54.79% |
| 2018-12-31 | $19.09M | 143.57% |
| 2018-09-30 | $7.84M | 37.38% |
| 2018-06-30 | $5.70M | -1.54% |
| 2018-03-31 | $5.79M | 43.39% |
| 2017-12-31 | $4.04M | -76.91% |
| 2017-09-30 | $17.50M | 15.88% |
| 2017-06-30 | $15.10M | - |
| 2017-03-31 | $15.10M | - |
Sutro Biopharma generated $9.69M in revenue during Q3 2025, up -84.79% compared to the previous quarter, and up 37.71% compared to the same period a year ago.
Sutro Biopharma Revenue Breakdown
Sutro Biopharma Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 18 |
|---|---|---|---|
| Research and Development Services | $71.00K | $174.00K | - |
| Other Revenue | - | - | $5.42M |
| Collaboration Revenue | - | - | $13.54M |
Sutro Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 25: Research and Development Services (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Dec 18 | Sep 18 |
|---|---|---|---|---|
| Operating Segments | $9.69M | $63.74M | - | - |
| Collaboration Revenue | - | - | $18.43M | - |
| Other Revenue | - | - | $654.00K | $912.00K |
Sutro Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Operating Segments (100.00%).
Sutro Biopharma Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 18 |
|---|---|
| Other Revenue | $5.42M |
| Collaboration Revenue | $13.54M |
Sutro Biopharma's latest annual revenue breakdown by geography, as of Dec 18: Collaboration Revenue (71.40%), and Other Revenue (28.60%).
Quarterly Revenue by Country
| Country | Dec 18 | Sep 18 |
|---|---|---|
| Other Revenue | $654.00K | $912.00K |
| Collaboration Revenue | $18.43M | - |
Sutro Biopharma's latest quarterly revenue breakdown by geography, as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).
Sutro Biopharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STRO | Sutro Biopharma | $102.48M | $9.69M |
| DTIL | Precision BioSciences | $34.26M | $10.84M |
| MGX | Metagenomi | $25.21M | $1.25M |
| STTK | Shattuck Labs | $1.00M | - |
| IFRX | InflaRx | $61.80K | $36.25K |
| GUTS | Fractyl Health | - | - |
| CNTB | Connect Biopharma | - | $48.00K |
| ARTV | Artiva Biotherapeutics | - | - |
| KLRS | Kalaris Therapeutics | - | - |
| PLRX | Pliant Therapeutics | - | - |